Licoisoflavone B and glabridin from Glycyrrhiza glabra as potent nucleoprotein antagonists of Lassa virus: insights from molecular docking, dynamics simulation, PCA, and DFT studies
Lassa virus causes a severe hemorrhagic disease referred to as Lassa fever. It exhibits a significant mortality rate among people in West and Central Africa. Currently, there is no vaccine available, and ribavirin is the sole treatment option with significant limitations. Given the lack of an effect...
Saved in:
| Main Authors: | Sk. Faisal Ahmed, Md. Masudur Rahman Munna, Md. Hossain Ahmed, Md. Mostafizur Rahman, Minhajul Islam, Esha Mony Bristy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | Journal of Genetic Engineering and Biotechnology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1687157X25000885 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In-silico screening of small compounds against Lassa fever haemorrhagic virus nucleoprotein
by: Ekpo Eyo Antai, et al.
Published: (2025-08-01) -
The epidemiology of Lassa fever in Ghana: a study on the 2023 Lassa fever outbreak in Ghana
by: Kwasi Atweri Akowuah, et al.
Published: (2025-04-01) -
Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
by: Anges Yadouleton, et al.
Published: (2020-01-01) -
Assessing the Environmental Drivers of Lassa Fever in West Africa: A Systematic Review
by: Natalie A. Davis, et al.
Published: (2025-03-01) -
Lassa fever outbreak in Newaken Community, Grand Kru County, Liberia, September-October 2017
by: Jimmy Gboluma Lawubah, et al.
Published: (2021-01-01)